Is the priority review voucher program stimulating new drug development for tropical diseases?

Authors :: Kerr KW
Henry TC
Miller KL
Source :: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Aug 09; Vol. 12 (8), pp. e0006695. Date of Electronic Publication: 2018 Aug 09 (Print Publication: 2018).
Publication Year :: 2018
Abstract: Congress created the tropical disease priority review voucher program to stimulate new drug development for tropical diseases. An analysis of the pharmaceutical pipeline indicates that the development of drugs for these tropical diseases has increased. However, the effects of the program are not uniform across all diseases, as malaria and tuberculosis have seen significant new drug development, while other diseases have not.<br />Competing Interests: The authors have declared that no competing interests exist.

Subjects :: Humans
United States
United States Food and Drug Administration trends
Drug Approval legislation & jurisprudence
Drug Discovery legislation & jurisprudence
Drug Discovery trends
Drug Industry trends
Tropical Medicine
United States Food and Drug Administration legislation & jurisprudence

Full Text Access

Tools